Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.33 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.33 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | CCND3 | P30281 | 1/20 | 0.31 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31142510 | 0.81 | MEN1 (0.39) | MEN1KMT2ACASP3RAB9AATM | |
| SCHEMBL38660687 | 0.80 | TDP1 (0.41) | MEN1KMT2ACASP3RAB9AATM | |
| SCHEMBL2344035 | 0.77 | MEN1 (0.39) | MEN1KMT2ACASP3RAB9AATM | |
| SCHEMBL5460906 | 0.77 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL29869219 | 0.75 | RXRA (0.37) | MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL47326 | 0.75 | RXRA (0.37) | MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL11839777 | 0.74 | MEN1 (0.37) | MEN1KMT2A | |
| SCHEMBL5850640 | 0.74 | MEN1 (0.37) | MEN1KMT2ACASP3RAB9AATM | |
| SCHEMBL4502019 | 0.74 | MEN1 (0.37) | MEN1KMT2ACCNE2CDK2CCND3 | |
| SCHEMBL3216062 | 0.74 | EHMT2 (0.53) | MEN1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4015518-B1 | ACTIVE-TARGETING NEAR-INFRARED FLUORESCENT MOLECULE FOR TARGETING FOLATE RECEPTOR AND PREPARATION METHOD THEREFOR | NANJING NUOYUAN MEDICAL DEVICES CO LTD (CN) | 2023-10-25 | — | — | EP | disclosed |
| WO-2020251093-A1 | RENAL CLEARABLE FLUORESCENT CONTRAST AGENT WITH INCREASED TUMOR SPECIFICITY, AND IMAGING METHOD USING SAME | 나우비젼 주식회사 | 2020-12-17 | — | — | WO | disclosed |
| EP-1981846-B1 | MARKERS, METHOD FOR MANUFACTURING THEM AND THEIR APPLICATIONS | LABORATOIRES SYNTH-INNOVE (FR) | 2017-11-01 | — | — | EP | disclosed |
| US-9687567-B2 | Charged-balanced imaging agents | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| US-20120045851-A1 | LABELS, THEIR PRODUCTION PROCESS AND THEIR USES | LABORATOIRES SYNTH-INNOVE (FR) | 2012-02-23 | — | — | US | disclosed |
| US-20120045851-A1 | LABELS, THEIR PRODUCTION PROCESS AND THEIR USES | LABORATOIRES SYNTH-INNOVE (FR) | 2012-02-23 | — | — | US | disclosed |
| EP-2006289-B1 | PYRAZOLE-TYPE CYANINE DYE | WAKO PURE CHEM IND LTD (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-8034626-B2 | Labels, their production process and their uses | LABORATOIRES SYNTH-INNOVE (FR) | 2011-10-11 | — | — | US | disclosed |
| US-8034626-B2 | Labels, their production process and their uses | LABORATOIRES SYNTH-INNOVE (FR) | 2011-10-11 | — | — | US | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
| WO-2009152440-A1 | SMALL MOLECULE LIGAND-DRUG CONJUGATES FOR TARGETED CANCER THERAPY | CEDARS-SINAI MEDICAL CENTER (US) | 2009-12-17 | — | — | WO | disclosed |
| US-20090069546-A1 | PYRAZOLE-BASED CYANINE DYE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| US-7473415-B2 | Near infrared fluorescent contrast agent and method for fluorescence imaging | FUJI PHOTO FILM CO., LTD. (JP) | 2009-01-06 | — | — | US | disclosed |
| US-20080318336-A1 | Labels, Their Production Process And Their Uses | LABORATOIRES SYNTH-INNOVE (FR) | 2008-12-25 | — | — | US | disclosed |
| US-20080318336-A1 | Labels, Their Production Process And Their Uses | LABORATOIRES SYNTH-INNOVE (FR) | 2008-12-25 | — | — | US | disclosed |
| US-7411068-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2008-08-12 | — | — | US | disclosed |
| WO-2007017602-A2 | MARQUEURS, LEUR PROCEDE DE FABRICATION ET LEURS APPLICATIONS | LABORATOIRES SYNTH-INNOVE (FR) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | MEN1 1430/4885KMT2A 2404/4885CASP3 1560/4885 |
| US-20090069546-A1 | PYRAZOLE-BASED CYANINE DYE | CBR3, CYB5R3, TST | MEN1 3812/4885KMT2A 3739/4885CASP3 291/4885 |
| US-20120045851-A1 | LABELS, THEIR PRODUCTION PROCESS AND THEIR USES | HLCS, PFAS, CYBA | MEN1 3867/4885KMT2A 2800/4885CASP3 2359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.